Abstract
BackgroundMethotrexate (MTX) is the most commonly used disease modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Methotrexate pneumonitis (MP) is a potentially fatal hypersensitivity reaction with a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have